Get started
Author

Ting Ying Ng

Observed names: Ng, Ting, Ting Y. Ng
Institution: Tuen Mun Hospital
OpenAlex ID: A5114054998
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
2017 · Miguel Martin, Frankie A Holmes, et al. · The Lancet Oncology · 587
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma
2025 · Michael Wang, Michael Wang, et al. · Journal of Clinical Oncology · 67
Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis
2019 · Shing Fung Lee, Ting Ying Ng, et al. · BMC Cancer · 34
PDF
Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1
2017 · Masakazu Toi, Zhimin Shao, et al. · Breast Cancer Research · 34
PDF
Knowledge, attitudes and intention on fertility preservation among breast cancer patients
2023 · Jennifer K. Y. Ko, Charleen S. Y. Cheung, et al. · Scientific Reports · 22
PDF
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens
2021 · Ming-Shen Dai, Yin Hsun Feng, et al. · Breast Cancer Research and Treatment · 22
PDF
The Value of Prognostic Nutritional Index in Follicular Lymphoma
2018 · Shing Fung Lee, Ting Ying Ng, et al. · American Journal of Clinical Oncology · 20
Clinical features and treatment outcomes of Hodgkin’s lymphoma in Hong Kong Chinese
2014 · Man Fai Law, Ting Ying Ng, et al. · Archives of Medical Science · 8
PDF
Aspirin and risk of multiple myeloma in adults: A systematic review and meta-analysis
2017 · Shing Fung Lee, Ting Ying Ng, et al. · Leukemia Research Reports · 5
PDF
The Role of Radiotherapy in Early-stage Primary Diffuse Large B-Cell Lymphoma of the Waldeyer Ring
2017 · Shing Fung Lee, Ting Ying Ng, et al. · American Journal of Clinical Oncology · 4
Real-world use of neratinib as extended adjuvant therapy in HER2-positive early-stage breast cancer: a multicentre study in mainland China and Hong Kong
2026 · Nilupai Abudureheiyimu, Yueran Jia, et al. · The Breast · 1
Survival outcomes of high and intermediate-risk hormone receptor (HR)-positive human epidermal growth receptor-2 (HER2)-negative early breast cancer patients (EBC) who did and did not receive (neo)adjuvant chemotherapy.
2026 · Winnie Yeo, Lok-Wa Yuen, et al. · Journal of Clinical Oncology
Real-world evidence of mammography screening from the Hong Kong Breast Cancer Registry: a cost minimisation analysis of 15 144 patients with breast cancer
2026 · Ziyu Hao, Amy Lam, et al. · BMJ Public Health
Expert consensus recommendations on the daily clinical use of pembrolizumab for early triple-negative breast cancer
2025 · Winnie Yeo, Yolanda HY Chan, et al. · Hong Kong Medical Journal
PDF
Expert consensus recommendations on the daily clinical use of pembrolizumab for early triple-negative breast cancer.
2024 · Winnie Yeo, Yolanda HY Chan, et al. · Journal of Clinical Oncology
A case-control study of 10,757 individuals to assess potentially modifiable risk factors, including stress, for breast cancer among Chinese patients in Hong Kong.
2023 · Winnie Yeo, Lok-Wa Yuen, et al. · Journal of Clinical Oncology
A young man with a mass on the neck
2018 · Shing Fung Lee, Ting Ying Ng, et al. · BMJ
Additional file 1: of Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1
2017 · Toi, Masakazu, Shao, Zhimin, et al. · Figshare
Additional file 2: of Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1
2017 · Toi, Masakazu, Shao, Zhimin, et al. · Figshare
OOTR-N006: mTOR inhibition with everolimus in invasive breast cancer patients after pre-operative use of anthracycline and/or taxane-based chemotherapy.
2016 · Louis W.C. Chow, Seock-Ah Im, et al. · Journal of Clinical Oncology
Works count: 20
Citation count: 802
H-index: 8
I10-index: 7
Year
Topic
Type